Granite Point Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Granite Point Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-75,000	Closed	-$7.18M	–	209
2020 Q4	$7.18M	Buy	75,000 +55,000	+275%	+$5.67M	0.37%	25
2020 Q3	$2.27M	Sell	20,000 -80,000	-80%	-$8.41M	0.12%	88
2020 Q2	$9.89M	Buy	+100,000	New	+$7.98M	0.5%	23
2019 Q1	–	Sell	-100,000	Closed	-$3.8M	–	132
2018 Q4	$3.8M	Sell	100,000 -150,000	-60%	-$5.3M	0.77%	25
2018 Q3	$10.7M	Buy	+250,000	New	+$8.73M	0.71%	22

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Granite Point Capital Management's TNDM Position: Q2 2023 in Review

Granite Point Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 15,000 shares — an estimated $609K sold.

Granite Point Capital Management first reported a position in TNDM in Q4 2013 and held it in 20 quarters. The position peaked at $7.45M in Q2 2020. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Granite Point Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
Granite Point Capital Management sold 15,000 Tandem Diabetes Care shares in Q2 2023, an estimated $609K.
Granite Point Capital Management first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 20 quarters.
Granite Point Capital Management's Tandem Diabetes Care position peaked at $7.45M in Q2 2020.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Granite Point Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.